Evaluation of echocardiographic prognostic parameters in patients with cardiac valve disease

• Conditions: I35.0; I35.2; I36.1; I34.0; I34.8; I08.0; I08.1; I08.2; I08.3; Aortic (valve) stenosis

• Registration Number: DRKS00024897
• Lead Sponsor: Klinikum Friedrichshafen GmbH Klinik für Kardiologie, Angiologie, Pneumologie und internistische Intensivmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

>18 years
written informed consent
moderate or severe valvular disease (aortic stenosis, mitral valve insufficiency), tricuspid valve insufficiency)

Exclusion Criteria

Age <18 years
No high-grade or moderate-grade valvular heart disease
No written informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Which echocardiographic parameters are prognostically relevant in patients with<br>a) an isolated valvular defect (aortic stenosis, mitral valve insufficiency), or tricuspid valve insufficiency)<br>b) Presence of a combination of two valvular defects<br>c) Presence of all three valvular defects

Secondary Outcome Measures

Name	Time	Method
Which combination of clinical and echocardiographic parameters shows prognostic value in patients with as well as in patients without indication for cardiac surgery or interventional repair of the valvular defect.